05:00 PM, 14th Jan 2026
Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025.